1-4 of 4
Caitlin Sarubbi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Model for Predicting Day-100 Stem Cell Transplant-Related Mortality in AL Amyloidosis

Eli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, Hamza Hassan, Raphael Mwangi, Matthew J. Maurer, Francis Buadi, Hans C. Lee, Muzaffar H. Qazilbash, Andrew Kin, Jeffrey A. Zonder, Sally Arai, Michelle M Chin, Rajshekhar Chakraborty, Suzanne Lentzsch, Hila Magen, Eden Shkury, Caitlin Sarubbi, Heather J. Landau, Stefan Schonland, Ute Hegenbart, Morie A. Gertz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4681.
https://doi.org/10.1182/blood-2024-206496
Published: 2024
Journal Articles

The Impact of Melphalan Conditioning Schedule on Post-Transplant Outcomes in AL Amyloidosis: A Multicenter Study with 1718 Patients

Eli Muchtar, Vaishali Sanchorawala, Hamza Hassan, Ute Hegenbart, Stefan Schonland, Hans C. Lee, Muzaffar H. Qazilbash, Andrew Kin, Christiane A. Houde, Francis Buadi, Angela Dispenzieri, Eapen K. Jacob, Sally Arai, Michelle Chin MD, Rajshekhar Chakraborty, Suzanne Lentzsch, Hila Magen, Eden Shkury, Caitlin Sarubbi, Heather Landau, Morie A Gertz
Journal: Blood
Blood (2023) 142 (Supplement 1): 4784.
https://doi.org/10.1182/blood-2023-188115
Published: 2023
Journal Articles

Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis

Gunjan L. Shah, MD, Heather Landau, MD, Caitlin Sarubbi, A.B, Ryan Schofield, MS, Andrew Lin, PharmD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Sean M. Devlin, PhD, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3296.
https://doi.org/10.1182/blood.V130.Suppl_1.3296.3296
Published: 2017
Journal Articles

Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Gunjan L. Shah, MD, Andrew Lin, PharmD, Ryan Schofield, MS, Caitlin Sarubbi, AB, Elaina V. Preston, PA-C,MPH, Sean M. Devlin, PhD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Elizabeth Hoover, BS, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD, Heather Landau, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2023.
https://doi.org/10.1182/blood.V130.Suppl_1.2023.2023
Published: 2017